Common Contracts
1 similar null contracts
INVESTMENT AGREEMENTS WITH SHANDONG SHANGHE ECONOMIC DEVELOPMENT ZONEAugust 15th, 2018
This is a voluntary announcement made by Genscript Biotech Corporation (the “Company”, together with its subsidiaries, the “Group”). The board (the “Board”) of directors (the “Directors”) of the Company is pleased to announce that on 15 August 2018, its indirect wholly-owned subsidiary, Bestzyme Biotech HK Limited 香港百斯杰生物科技有限公司 (“BSJ Hong Kong”), entered into an agreement and a supplemental agreement with Shandong Shanghe Economic Development Zone Management Committee* 山東商河經濟開發區管理委員會 (the “Committee”) in relation to the investment in the production and sale of bio-fermentation products in the economic development zone (the “Shanghe Economic Development Zone”) managed by the Committee (collectively, the “Investment Agreements”).
